×
About 345,515 results

Gocovri Clinical Data
https://www.gocovrihcp.com/clinical-data/
Gocovrihcp.com

May 28th, 2020 - The efficacy and safety of GOCOVRI® 274 mg were evaluated in two Phase 3, randomized, placebo-controlled trials

FDA approves brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma
https://www.fda.gov/drugs/fda-approves-brexucabtagene-autoleucel-relapsed-or-refractory-mantle-cell-lymphoma
FDA

Jul 24th, 2020 - The Food and Drug Administration granted accelerated approval to brexucabtagene autoleucel (TECARTUS, Kite, a Gilead Company), a CD19-directed genetically modified autologous T cell immunotherapy, for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL).

Staples hand sanitizer aloe - alcohol liquid-Staples
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1ee01914-3063-4805-8980-3422c248933f

Apr 30th, 2022 - Hand sanitizer to help reduce bacterial on the skin that could cause diseaseAntimicrobial

Staples hand sanitizer - alcohol gel-Staples
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e848a095-f9f4-406b-b7cb-47288eac3686

Apr 25th, 2022 - Hand sanitizer to help reduce bacteria on the skinAntimicrobial

U.S. FDA Approves Evofem Biosciences' Phexxi™ (lactic acid, citric acid and potassium bitartrate), the First and Only Non-Hormonal Prescription Gel for the Prevention of Pregnancy
https://evofem.investorroom.com/2020-05-22-U-S-FDA-Approves-Evofem-Biosciences-Phexxi-TM-lactic-acid-citric-acid-and-potassium-bitartrate-the-First-and-Only-Non-Hormonal-Prescription-Gel-for-the-Prevention-of-Pregnancy

Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.

Remdesivir Clinical Trials
https://www.gilead.com/purpose/advancing-global-health/covid-19/remdesivir-clinical-trials

The remdesivir clinical trial program was designed to answer multiple scientific questions in parallel, to rapidly evaluate the potential for remdesivir to treat COVID-19 patients.

Gocovri Prescribing Information
https://www.gocovrihcp.com/pdf/Gocovri_Prescribing_Information.pdf

Gocovri Prescribing Information, PI, Parkinson Disease, PD

Levetiracetam - levetiracetam tablet, film coated-Solco Healthcare US, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd713e60-478c-43cd-b680-ff594a0b3864

Jan 8th, 2022 - Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older (1.1) Levetiracetam is indicated for adjunctive therapy for the treatment of: •Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy (1.2) •Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilep...

Purell advanced refreshing aloe - alcohol gel-GOJO Industries, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3330c320-49f3-4dd0-a1bd-39c1f9632370

Jan 1st, 2022 - Hand sanitizer to help reduce bacteria on the skinAntimicrobial

Purell advanced with aloe instant hand sanitizer - alcohol liquid-GOJO Industries, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ffe7751-4bee-482c-ac50-ae4d6156657b

Jan 1st, 2022 - Hand sanitizer to help reduce bacterial on the skin that could cause diseaseAntimicrobial

Bupropion hydrochloride - bupropion hydrochloride tablet, film coated, extended release-Proficient Rx LP
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e57451fd-aba5-47d6-9892-ffe2a6021b6f

Jan 1st, 2022 - Bupropion hydrochloride extended-release tablets (XL) are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD). Periodically reevaluate long-term usefulness for the individual patient. (1) Bupropion hydrochloride extended-release tablets (XL) are indicated for the treatment of major depressive disorder ...

Hand sanitizer - alcohol liquid-Star Union Spirits
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a256329e-386f-2a01-e053-2a95a90a18d7

Dec 30th, 2021 - Hand Sanitizer to help reduce bacteria that potentially can cause disease. For use when soap and water are not available.Antiseptic, Hand Sanitizer

Is clinical hand sanitizing gel - ethyl alcohol gel-Science of Skincare
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6387d2a-f95c-5c1b-e053-2a95a90a83eb

Dec 11th, 2021 - to help reduce bacteria on the skin.Antiseptic

Hand sanitizer - alcohol gel-AZ ALCOHOL INC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b72361f4-22e6-683d-e053-2995a90a000e

Dec 6th, 2021 - Hand Sanitizer to help reduce bacteria that potentially can cause disease. For use when soap and water are not available.Antiseptic, Hand Sanitizer

Qwo™ Is Now FDA Approved - Endo Aesthetics
https://www.Qwo.com/Now/FDA-Approved

Qwo™ (collagenase clostridium histolyticum-aaes) Is Now FDA Approved. Check Out The Press Release & Sign Up For More Information From Endo Aesthetics Today. Official Product Site · Sign Up For Updates · Indication

Blenrep - Official HCP Website - View Prescribing Information
https://www.blenrephcp.com/

HCPs - Learn About Now Approved BLENREP (belantamab mafodotin-blmf). View Boxed Warning.

The Birth Of Something New - BREZTRI AEROSPHERE™
https://breztrihcp.com/

(budesonide/glycopyrrolate/formoterol fumarate) Now Approved. Visit The Physician Site. Explore A New Approved Treatment Option. Be The First To Learn About BREZTRI. Now Approved. Prescribing Information. Register For Updates. Learn The Pronunciation.

MYCAPSSA® (octreotide) Oral - Capsules Is Now FDA-Approved‎
https://hcp.mycapssa.com/

MYCAPSSA® (octreotide) delayed-release oral capsules is the first and only FDA-approved oral somatostatin analog (SSA) for appropriate patients with acromegaly, providing effective and consistent biochemical control, while freeing patients from the burden of injections.

CYSTADROPS (cysteamine ophthalmic solution) 0.37%
https://www.cystadrops.com/

CYSTADROPS (cysteamine ophthalmic solution) 0.37% is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis.

Evrysdi™ (risdiplam) - Healthcare Professionals Site
https://www.evrysdi-hcp.com/

Visit Official HCP Site to See if Evrysdi™ Could be an Option for Your Patients. Evrysdi Challenges. Evrysdi Education. Evrysdi Resources. Evrysdi Treatment. Types: Learn About Evrysdi, Clinical Trial Results, Safety and Efficacy, Potential Benefits.